Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

247
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
247
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

216
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
216
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

84
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
84

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

TIA-1 promotes FUNDC1-mediated mitophagy to protect against stress-induced cellular senescence.

Experimental & molecular medicine·2026
Same author

Essential Data Elements for Laboratory Test Interoperability: An Expert Consensus-Based Framework.

Annals of laboratory medicine·2026
Same author

Prediction of postoperative desaturation and bradycardia in neonates undergoing laparoscopic inguinal hernia repair: a retrospective cohort study.

Anesthesia and pain medicine·2026
Same author

Risk Prediction Based on Clinicopathologic Features in Korean Melanoma Patients by Machine Learning.

Cancer research and treatment·2026
Same author

SkinECG: An orthogonal remote powering wearable skin-like sensor.

Science advances·2026
Same author

Diagnostic Utility of Dysmorphic Erythrocyte Identification Using the Atellica 1500 Automated Urinalysis System in the Evaluation of Glomerular Hematuria.

Archives of pathology & laboratory medicine·2026

相关实验视频

Updated: Jul 12, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

在万科米辛治疗中,以模型为基础的精确剂量.

Sukyong Yoon1,2, Jinju Guk1,2, Sang-Guk Lee3

  • 1Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea.

Frontiers in pharmacology
|October 25, 2023
PubMed
概括
此摘要是机器生成的。

这项研究开发了一个精确的剂量模型,用于万科米辛 (一种抗生素),以优化治疗和减少毒性. 该模型有助于确定理想的剂量和持续时间,确保有效性,同时尽量减少损伤等副作用.

关键词:
在C-反应性蛋白质中.这不是nonmemem.R 闪亮的闪亮的基于模型的精确剂量定量.最佳的剂量是最优的剂量.药学动力学上的药理学.药物动力学 药物动力学这就是Vancomycin.

更多相关视频

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.4K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.9K

相关实验视频

Last Updated: Jul 12, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.4K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.9K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 临床药房 临床药房
  • 制药指标 (Pharmacometrics) 是一个指标.

背景情况:

  • 范科米辛是一种关键的抗生素,但与耳毒性和毒性有关.
  • 度依赖性毒性和过度处理需要优化剂量策略.

研究的目的:

  • 开发一个人群的药理动力学 (PK) 和药理动力学 (PD) 模型,用于菌素.
  • 建立基于模型的精确剂量计划,以获得最佳剂量和治疗持续时间.
  • 为了最大限度地减少万科米辛诱导的毒性.

主要方法:

  • 使用NONMEM软件分析了542名患者 (包括40名儿童) 的电子病历.
  • 开发一个双隔间的PK模型,用于万科胺度的全米缩放.
  • 模拟C-反应蛋白 (CRP) 血度,使用运输区进行PD分析.

主要成果:

  • 范科米辛的清除受肌素,BUN,糖尿病,病史和性别的影响;分布量随着年龄的增长而增加.
  • 肺炎的CRP水平下降,并得到了有效的建模.
  • 模拟显示,最佳剂量维持了潜在较低剂量的治疗度,较高剂量加速了CRP的减少.

结论:

  • 一个群体PK/PD模型可以指导科米的精确剂量.
  • 该模型有助于设计最佳的万科米辛治疗方案,以减少毒性.
  • 一个R Shiny应用程序可以实现高效的可视化,用于设计个性化的治疗方案.